Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer
- 13 October 2011
- journal article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 17 (6), 590-597
- https://doi.org/10.1007/s10147-011-0329-9
Abstract
Background Pathological detection of lymphovascular space invasion (LVSI) is a useful prognostic marker for patients with endometrial cancer. However, LVSI is criticized for its subjectivity and poor reproducibility. To improve the outcomes of patients with endometrial cancer, we evaluated objective parameters associated with LVSI to generate more accurate LVSI assessments and to identify patients with high-risk disease. Methods We reviewed the medical records of 137 patients with endometrial cancer. Flow cytometry was used to determine DNA ploidy and S-phase fraction. Estrogen and progesterone receptor (ER and PR) levels and p53 and k-ras mutational status were tested. Results LVSI was found in 36 patients (26.3%). Patients with LVSI had significantly decreased recurrence-free survival and overall survival compared to those without LVSI. Aneuploid tumors were significantly more frequent in LVSI-positive patients compared with LVSI-negative patients (odds ratio = 5.208, P < 0.001). With the exception of p53 mutational status, there was a statistically significant relationship between LVSI and other parameters tested. However, by multivariate analysis, DNA ploidy and S-phase fraction were significantly correlated with LVSI (P = 0.034 and 0.001, respectively). Conclusion Ploidy and S-phase fraction correlate with LVSI, which is a significant independent predictor of clinical outcome in patients with endometrial cancer.Keywords
This publication has 24 references indexed in Scilit:
- Current status in the management of uterine corpus cancer in KoreaJournal of Gynecologic Oncology, 2010
- The role of DNA ploidy in postoperative management of stage I endometrial cancerAnnals of Oncology, 2008
- Ten‐year results of a prospective study on the prognostic role of ploidy in endometrial carcinomaCancer, 2007
- DNA aneuploidy is associated with increased mortality for stage I endometrial cancerGynecologic Oncology, 2004
- A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancerInternational Journal of Gynecologic Cancer, 2004
- Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinomaCancer, 2004
- Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinomaInternational Journal of Gynecologic Cancer, 2002
- FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancersInternational Journal of Gynecology & Obstetrics, 2000
- Potential Therapeutic Role of Para-aortic Lymphadenectomy in Node-Positive Endometrial CancerGynecologic Oncology, 2000
- Carcinoma of the Endometrium: Do the Nuclear Grade and DNA Ploidy Provide More Prognostic Information than Do the FIGO and WHO Classifications?International Journal of Gynecological Pathology, 1996